0
0.5
1
1.5
2+
Mortality
64%
Improvement
Relative Risk
Death/ICU
44%
ICU admission
37%
Hospitalization
39%
HCQ for COVID-19 Sulaiman et al. EARLY TREATMENT
Is early treatment with HCQ beneficial for COVID-19?
Prospective study of 7,892 patients in Saudi Arabia
Lower mortality (p=0.012) and death/ICU (p=0.019) with HCQ
c19hcq.org
Sulaiman et al., medRxiv, September 2020
Favors HCQ
Favors control